APA (7th ed.) Citation

An, H., Lim, C., Guillemin, G. J., Vollmer-Conna, U., Rawlinson, W., Bryant, K., & Tedla, N. (2016). Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

An, Hongyan, Chai Lim, Gilles J. Guillemin, Ute Vollmer-Conna, William Rawlinson, Katherine Bryant, and Nicodemus Tedla. Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility. Public Library of Science (PLoS), 2016.

MLA (9th ed.) Citation

An, Hongyan, et al. Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility. Public Library of Science (PLoS), 2016.